BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33914139)

  • 21. Multifocal autoimmune pancreatitis: A retrospective study in a single tertiary center of 26 patients with a 20-year literature review.
    Huang XM; Shi ZS; Ma CL
    World J Gastroenterol; 2021 Jul; 27(27):4429-4440. PubMed ID: 34366614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma.
    Kambadakone AR; Zaheer A; Le O; Bhosale P; Meier J; Guimaraes AR; Shah Z; Hough DM; Mannelli L; Soloff E; Friedman A; Tamm E
    Abdom Radiol (NY); 2018 Feb; 43(2):245-252. PubMed ID: 29277858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 24. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
    Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
    Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
    Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis.
    Ichikawa S; Kromrey ML; Motosugi U; Onishi H
    Abdom Radiol (NY); 2021 Feb; 46(2):636-646. PubMed ID: 32740865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory mimickers of pancreatic adenocarcinoma.
    Kothari K; Lopes Vendrami C; Kelahan LC; Shin JS; Mittal P; Miller FH
    Abdom Radiol (NY); 2020 May; 45(5):1387-1396. PubMed ID: 31559473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
    Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
    Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
    Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
    AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
    [No Abstract]   [Full Text] [Related]  

  • 32. Non-gaussian models of 3-Tesla diffusion-weighted MRI for the differentiation of pancreatic ductal adenocarcinomas from neuroendocrine tumors and solid pseudopapillary neoplasms.
    Shi YJ; Li XT; Zhang XY; Zhu HT; Liu YL; Wei YY; Sun YS
    Magn Reson Imaging; 2021 Nov; 83():68-76. PubMed ID: 34314825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
    Kim JH; Park SH; Yu ES; Kim MH; Kim J; Byun JH; Lee SS; Hwang HJ; Hwang JY; Lee SS; Lee MG
    Radiology; 2010 Oct; 257(1):87-96. PubMed ID: 20697118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
    Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
    Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pitfalls in the MDCT of pancreatic cancer: strategies for minimizing errors.
    Haj-Mirzaian A; Kawamoto S; Zaheer A; Hruban RH; Fishman EK; Chu LC
    Abdom Radiol (NY); 2020 Feb; 45(2):457-478. PubMed ID: 31897686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraduodenal pancreatitis as a mimicker of pancreatic adenocarcinoma: MRI evaluation.
    Boninsegna E; Negrelli R; Zamboni GA; Tedesco G; Manfredi R; Pozzi Mucelli R
    Eur J Radiol; 2017 Oct; 95():236-241. PubMed ID: 28987673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreas ductal adenocarcinoma with cystic features on cross-sectional imaging: radiologic-pathologic correlation.
    Youn SY; Rha SE; Jung ES; Lee IS
    Diagn Interv Radiol; 2018; 24(1):5-11. PubMed ID: 29317372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Diagnosis of Nonhypervascular Pancreatic Neuroendocrine Neoplasms From Pancreatic Ductal Adenocarcinomas, Based on Computed Tomography Radiological Features and Texture Analysis.
    Yu H; Huang Z; Li M; Wei Y; Zhang L; Yang C; Zhang Y; Song B
    Acad Radiol; 2020 Mar; 27(3):332-341. PubMed ID: 31495760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.